Shift from high-frequency to low-frequency episodic migraine in patients treated with Galcanezumab: results from two global randomized clinical trials

被引：0
|
作者：
Jakub Jedynak
Eric Eross
Astrid Gendolla
Mallikarjuna Rettiganti
Virginia L. Stauffer
机构：
[1] Eli Lilly and Company,
[2] Phoenix Headache Institute,undefined
[3] Praxis Gendolla,undefined
来源：
The Journal of Headache and Pain | 2021年 / 22卷
关键词：
QoL; MIDAS; MSQ-RFR; Episodic migraine; Sustained improvement; Migraine frequency;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Shift from high-frequency to low-frequency episodic migraine in patients treated with Galcanezumab: results from two global randomized clinical trials
    Jedynak, Jakub
    Eross, Eric
    Gendolla, Astrid
    Rettiganti, Mallikarjuna
    Stauffer, Virginia L.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (01):
  • [2] High Frequency Episodic Migraine Shift to Low Frequency Episodic Migraine in Patients Treated with Galcanezumab
    Stauffer, Virginia
    Jedynak, Jakub
    Gendolla, Astrid
    Eross, Eric
    Jin, Liequn
    CEPHALALGIA, 2019, 39 (1_SUPPL) : 398 - 399
  • [3] High Frequency Episodic Migraine Shift to Low Frequency Episodic Migraine in Patients Treated with Galcanezumab
    Stauffer, Virginia
    Jedynak, Jakub
    Gendolla, Astrid
    Eross, Eric
    Jin, Leah
    NEUROLOGY, 2020, 94 (15)
  • [4] Efficacy of galcanezumab in patients with episodic migraine and a history of preventive treatment failure: results from two global randomized clinical trials
    Ruff, D. D.
    Ford, J. H.
    Tockhorn-Heidenreich, A.
    Stauffer, V. L.
    Govindan, S.
    Aurora, S. K.
    Terwindt, G. M.
    Goadsby, P. J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 (04) : 609 - 618
  • [5] SHIFT FROM CHRONIC TO EPISODIC MIGRAINE STATUS AND HIGH- TO LOW-FREQUENCY EPISODIC MIGRAINE STATUS AMONG PATIENTS WITH TREATMENT-RESISTANT MIGRAINE IN A PHASE 3 GALCANEZUMAB STUDY
    Day, Kathleen A.
    Rettiganti, Mallik
    Ferguson, Margaret B.
    Stroud, Chad E.
    Trewin, Benjamin P.
    Takeshima, Takao
    Kingston, William S.
    CEPHALALGIA, 2020, 40 : 75 - 75
  • [6] Shift from chronic to episodic migraine frequency in a long-term phase 3 study of galcanezumab
    Diener, Hans-Christoph
    Day, Kathleen A.
    Lipsius, Sarah
    Aurora, Sheena K.
    Hindiyeh, Nada A.
    Detke, Holland C.
    JOURNAL OF HEADACHE AND PAIN, 2025, 26 (01):
  • [7] TEMPORARY THRESHOLD SHIFT FROM LOW-FREQUENCY AND HIGH-FREQUENCY INTERMITTENT NOISE AS A FUNCTION OF OFF TIME
    AHAUS, WH
    WARD, WD
    JOURNAL OF THE ACOUSTICAL SOCIETY OF AMERICA, 1972, 52 (01): : 130 - &
  • [8] DETERMINATION OF THE HIGH-FREQUENCY BEHAVIOR OF THE IMPEDANCE FROM LOW-FREQUENCY DATA
    HEIFETS, SA
    NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT, 1990, 295 (03): : 283 - 285
  • [9] Measuring high-frequency income risk from low-frequency data
    Klein, Paul
    Telyukova, Irina A.
    JOURNAL OF ECONOMIC DYNAMICS & CONTROL, 2013, 37 (03): : 535 - 542
  • [10] EFFECTS OF GALCANEZUMAB ON HEALTHCARE RESOURCE UTILIZATION AND ACUTE MEDICATION USE IN PATIENTS WITH MIGRAINE: RESULTS FROM TWO GLOBAL PHASE 3 CLINICAL TRIALS
    Ford, J. H.
    Foster, S. A.
    Detke, H. C.
    Stauffer, V. L.
    Ruff, D. D.
    Aurora, S. K.
    VALUE IN HEALTH, 2018, 21 : S208 - S208
12345